指南之指南:女性复发性尿路感染的管理
该综述比较了国际上九部主要泌尿外科与非泌尿外科机构发布的女性复发性尿路感染(rUTI)指南,检索时间为2022年3月。各指南在rUTI定义、评估和抗生素预防策略上基本一致,均强调获取尿培养并在无危险因素的女性中限制膀胱镜检查和上尿路影像学检查;但在对症治疗、自我启动抗生素及抗生素节省型预防策略方面建议不一。近期随机证据支持使用马尿酸乌洛托品。连续或性交后预防性抗生素得到所有指南支持。没有指南针对复发性复杂性尿路感染的管理。
要点
- 各指南在rUTI定义、评估和抗生素预防策略上基本一致,强调尿培养并限制无危险因素女性的膀胱镜和上尿路影像。
- 对症治疗、自我启动抗生素及抗生素节省型预防策略(如蔓越莓、阴道雌激素、OM-89免疫预防等)的建议存在差异。
- 近期随机证据支持使用马尿酸乌洛托品;连续或性交后预防性抗生素得到所有指南支持。
核心结论
- 识别出多部rUTI指南,其推荐大多限于其他方面健康的非妊娠女性无并发症膀胱炎。
- 抗生素节省型预防策略方面存在差异,部分矛盾推荐源于较新指南纳入了更新证据。
- 未来指南应考虑为复杂患者群体(如复发性复杂性UTI)的管理提供推荐。
研究设计与样本
- 指南比较综述,检索PubMed、Google Scholar及主要泌尿外科、妇科、感染病和全科医学机构官网,检索时间为2022年3月。
- 共纳入九部指南:欧洲泌尿外科学会、美国国家卫生与临床优化研究所(NICE)、加拿大妇产科医师学会、美国家庭医师学会、墨西哥妇产科专科医师学院、瑞士妇产科学会、西班牙感染病与临床微生物学会、德国科学医学协会联合会,以及美国泌尿外科学会/加拿大泌尿外科学会/尿动力学、女性盆底医学与泌尿生殖重建学会联合指南。
主要发现
- rUTI的定义和评估以及抗生素预防策略在多数指南间一致,强调获取尿培养并在无危险因素的女性中限制膀胱镜检查和上尿路影像学检查。
- 对症治疗、自我启动抗生素及抗生素节省型预防策略(如蔓越莓、阴道雌激素、OM-89免疫活性预防、膀胱内糖胺聚糖灌注和植物疗法)的建议存在差异。
- 近期随机证据支持使用马尿酸乌洛托品。
- 连续或性交后预防性抗生素得到所有指南支持。
- 没有指南针对复发性复杂性尿路感染的管理进行定制。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To compare recurrent urinary tract infection (rUTI) guidelines from major urological and non-urological organisations internationally and identify areas of consensus and discrepancy. METHODS: PubMed, Google Scholar and the official webpages of major urological, gynaecological, infectious diseases and general practice organisations were searched for rUTI guidelines in March 2022. Nine guidelines were included for review: European Association of Urology, National Institute for Health and Care Excellence (NICE), Society of Obstetricians and Gynaecologists of Canada, American Academy of Family Physicians, Mexican College of Gynaecology and Obstetrics Specialists, Swiss Society of Gynaecology and Obstetrics, Spanish Society of Infectious Diseases and Clinical Microbiology, German Association of Scientific Medical Societies, and the combined American Urological Association/Canadian Urological Association/Society of Urodynamics, Female Pelvic Medicine and Urogenital Reconstruction. RESULTS: The definition and evaluation of rUTIs, and antibiotic prophylaxis strategies, were mostly consistent across guidelines, and emphasised the importance of obtaining urine cultures and limiting cystoscopy and upper tract imaging in women without risk factors. Variable recommendations were noted for symptomatic treatment, self-initiated antibiotics, and antibiotic-sparing preventative strategies such as cranberry, vaginal oestrogen, immunoactive prophylaxis with OM-89, intravesical glycosaminoglycan instillation, and phytotherapeutics. Recent randomised evidence supports the use of methenamine hippurate. Either continuous or post-coital prophylactic antibiotics were supported by all guidelines. None of the guidelines were tailored to the management recurrent complicated UTI. CONCLUSION: Multiple rUTI guidelines were identified and mostly limited their recommendations to otherwise healthy non-pregnant women with uncomplicated cystitis. Variation was noted, particularly in antibiotic-sparing preventative strategies. Some conflicting recommendations are due to more recent guidelines including updated evidence. Future guidelines should consider recommendations to assist management of complex patient groups, such as recurrent complicated UTI.
引用
- Kwok M, McGeorge S, Mayer-Coverdale J, et al. Guideline of guidelines: management of recurrent urinary tract infections in women. BJU Int. 2022. PMID: 35579121. doi:10.1111/bju.15756
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。